| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Epidemiology Biomarkers & Prevention, Vol 1, Issue 6 505-513, Copyright © 1992 by American Association for Cancer Research
ARTICLES |
CI Amos, NE Caporaso and A Weston
Division of Biostatistics Research and Informatics, International Agency for Research on Cancer, Lyon, France.
Host-specific factors influence risk for lung cancer. A few case-control and family studies of lung cancer susceptibility allowed for known lung cancer carcinogens and showed strong familial clustering with some evidence for a codominantly acting major gene. Cytochrome P-450 enzymes (e.g., CYP1A1) activate many carcinogens in tobacco smoke but have shown inconsistent associations with risk for lung cancer. Case-control studies that assess the effects of CYPIID6 on lung cancer risk have consistently shown a mildly decreased risk for lung cancer among poor metabolizers. Cell surface markers have shown little relation to risk for lung cancer. Studies involving DNA or hemoglobin adducts, sister chromatid exchange, or oncogene activation only indirectly measure host-specific risk, and these assays have suffered from poor reproducibility and high cost. We describe epidemiological designs to assess specific genetic factors that may alter lung cancer risk.
This article has been cited by other articles:
|
|
 |
|
  S. C. O'Neill, G. Luta, B. N. Peshkin, A. Abraham, L. R. Walker, and K. P. Tercyak Adolescent Medical Providers' Willingness to Recommend Genetic Susceptibility Testing for Nicotine Addiction and Lung Cancer Risk to Adolescents J. Pediatr. Psychol., August 7, 2008; (2008) jsn086v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Sauter, A. Rosenberger, L. Beckmann, S. Kropp, K. Mittelstrass, M. Timofeeva, G. Wolke, A. Steinwachs, D. Scheiner, E. Meese, et al. Matrix Metalloproteinase 1 (MMP1) Is Associated with Early-Onset Lung Cancer Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1127 - 1135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Arizono, Y. Osada, and Y. Kuroda DNA Repair Gene hOGG1 Codon 326 and XRCC1 Codon 399 Polymorphisms and Bladder Cancer Risk in a Japanese Population Jpn. J. Clin. Oncol., March 1, 2008; 38(3): 186 - 191. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Alberg, M. V. Brock, and J. M. Samet Epidemiology of Lung Cancer: Looking to the Future J. Clin. Oncol., May 10, 2005; 23(14): 3175 - 3185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E Eberly, J. Ockene, R. Sherwin, L. Yang, and L. Kuller Pulmonary function as a predictor of lung cancer mortality in continuing cigarette smokers and in quitters Int. J. Epidemiol., August 1, 2003; 32(4): 592 - 599. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M Marteau and C. Lerman Genetic risk and behavioural change BMJ, April 28, 2001; 322(7293): 1056 - 1059. [Full Text]
|
|
|
|
|
|
R. Fan, M.-T. Wu, D. Miller, J. C. Wain, K. T. Kelsey, J. K. Wiencke, and D. C. Christiani The p53 Codon 72 Polymorphism and Lung Cancer Risk Cancer Epidemiol. Biomarkers Prev., October 1, 2000; 9(10): 1037 - 1042. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. W. Bergen and N. Caporaso Cigarette Smoking J Natl Cancer Inst, August 18, 1999; 91(16): 1365 - 1375. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
